AMANDA PHILLIPS: Open Payments
NPI 1699163014 · ATHENS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,096 in 60 payments from 11 companies in 2025. Trend: 2023 $1,224 · 2024 $1,211 · 2025 $1,096
Food & beverage: $1,096
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $261 |
| AstraZeneca Pharmaceuticals LP | 11 | $213 |
| ABBVIE INC. | 11 | $190 |
| Lilly USA, LLC | 8 | $149 |
| Amgen Inc. | 6 | $113 |
| Abbott Laboratories | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Philips North America LLC | 2 | $29 |
| Astellas Pharma US Inc | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
Products named: MOUNJARO, Wegovy, Ozempic, VRAYLAR, FARXIGA, OTEZLA, AIRSUPRA, FREESTYLE LIBRE 3.
Industry payments across AL — which companies pay providers there.
